PHOS MEDICAL WITH THE GREEK LETTER PHI - PH ? Trademark

Trademark Overview


On Thursday, December 26, 2024, a trademark application was filed for PHOS MEDICAL WITH THE GREEK LETTER PHI - PH ? with the United States Patent and Trademark Office. The USPTO has given the PHOS MEDICAL WITH THE GREEK LETTER PHI - PH ? trademark a serial number of 98922635. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, December 26, 2024. The PHOS MEDICAL WITH THE GREEK LETTER PHI - PH ? trademark is filed in the Medical Instrument Products category with the following description:

The PHENOM LASER stands out as the sole handheld therapeutic laser offering high power and intensity, harnessing four distinct wavelengths across both visible and invisible spectrums (infrared), ensuring optimal therapeutic results. It boasts user-friendly operation, complete portability, and operates on battery power." The PHENOM LASER employs four distinct wavelengths to achieve varying levels of penetration and provide comprehensive coverage across the therapeutic spectrum. The red light aiming beam, operating at a wavelength of 650nm with a power output of 200mW, is highly effective in targeting superficial and skin conditions. The high-intensity wavelengths of 810nm, 980nm, and 1064nm are designed for deeper tissue treatment, ensuring a broad range of therapeutic applications. Class IV laser
phos medical with the greek letter phi - ph ?

General Information


Serial Number98922635
Word MarkPHOS MEDICAL WITH THE GREEK LETTER PHI - PH ?
Filing DateThursday, December 26, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, December 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing0 - NOT AVAILABLE
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of The PHOS Medical LLC logo features "PHOS" with the "P" stylized as the Greek letter Phi (Ph), symbolizing balance, philosophy, and innovation. Radiating dots surround the Phi, resembling beams of light or energy, highlighting precision and technological advancement. Below "PHOS," "MEDICAL LLC" appears in a rectangular block for clarity and emphasis. The gradient teal color scheme conveys trust and modernity, while the overall design reflects the company's innovative, high-tech ethos.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesThe PHENOM LASER stands out as the sole handheld therapeutic laser offering high power and intensity, harnessing four distinct wavelengths across both visible and invisible spectrums (infrared), ensuring optimal therapeutic results. It boasts user-friendly operation, complete portability, and operates on battery power." The PHENOM LASER employs four distinct wavelengths to achieve varying levels of penetration and provide comprehensive coverage across the therapeutic spectrum. The red light aiming beam, operating at a wavelength of 650nm with a power output of 200mW, is highly effective in targeting superficial and skin conditions. The high-intensity wavelengths of 810nm, 980nm, and 1064nm are designed for deeper tissue treatment, ensuring a broad range of therapeutic applications. Class IV laser
Translation of Words in MarkThe English translation of PHOS MEDICAL with the Greek Letter Phi - Ph φ in the mark is The Greek letter Phi - Ph φ.

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, December 26, 2024
Primary Code010
First Use Anywhere DateThursday, July 20, 2023
First Use In Commerce DateMonday, December 9, 2024

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressFort Lauderdale, FL 33301

Trademark Events


Event DateEvent Description
Thursday, December 26, 2024NEW APPLICATION ENTERED